Abstract:Osteoporosis is known to be a common concomitant state in postmenopausal women with rheumatoid arthritis, but its development cannot be explained only by increasing of age, hormonal disorders, disease duration and glucocorticosteroid intake. Vitamin D deficiency may be one of the major risk factors, but its prevalence in the Ukrainian cohort of postmenopausal RA patients is unknown, and the factors on which it depends have not been established.To analyze the level of 25-hydroxyvitamin D [25 (OH) D] in postmenopausal women with rheumatoid arthritis (RA) and to investigate its relationship with the course of the disease, VDR (FokI) gene polymorphism and bone mineral density (BMD).The study included 81 postmenopausal RA patients and 21 postmenopausal age-matched women without RA as a control group. All patients were screened for demographic, disease course and treatment data. Serum 25-hydroxyvitamin D [25 (OH) D] level and VDR (FokI) gene polymorphism were measured by enzyme-linked immunosorbent assay (ELISA). Levels of 25-hydroxyvitamin D [25 (OH) D] 20-30 ng / ml were defined as insuficiency and less than 20 ng/ml as deficiency. BMD was measured in the lumbar spine and proximal femur using double X-ray absorptiometry. Osteoporosis was diagnosed in case of BMD> -2.5 T.The analysis has showed that serum vitamin D level in RA group was significantly lower than in control group (11.54 ng/ml vs. 15.25 ng/ml; p <0.01). In addition, the incidence of vitamin D insuficiency and deficiency was higher in RA patients than in control group. In particular, abnormal vitamin D level was diagnosed in 74.1% of RA patients, among whom 25 (30,9%) patients had vitamin D insuficiency and 35 (43.2%) patients had vitamin D deficiency. In control group 8 (38.1%) persons had vitamin D insuficiency, and 6 (28.6%) persons had vitamin D deficiency. There was an inverse correlation between vitamin D levels and RA activity assessed by DAS28 (p <0.001), CDAI (p = 0.001), ESR and CRP (p <0.001) but not with age, daily glucocorticosteroid dose and disease duration. In addition, significant correlation was revieled between VDR (FokI) gene polymorphism and vitamin D deficiency, as well as low BMD in postmenopausal women with rheumatoid arthritis (p <0.001)Low 25-hydroxyvitamin D [25 (OH) D] level and VDR (FokI) gene polymorphism are independent risk factors of osteoporosis in postmenopausal women with RA. Vitamin D deficiency is associated with RA activity and not depends on age, glucocorticosteroid daily dose and disease duration.None declared

AB0203 25-HYDROXYVITAMIN D [25 (OH) D] LEVEL IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS, ITS RELATIONSHIP WITH THE COURSE OF THE DISEASE, VDR (FokI) GENE POLYMORPHISM AND BONE MINERAL DENSITY.

Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Association between serum 25-hydroxyvitamin D levels and bone mineral density in normal postmenopausal women

Association of suboptimal 25-hydroxyvitamin D levels with knee osteoarthritis incidence in post-menopausal Egyptian women

Implications of vitamin D levels or status for mortality in rheumatoid arthritis: analysis of 2001-2018 data from the National Health and Nutrition Examination Survey

[Bone mineral density in women with rheumatoid arthritis: A link between immune and biochemical markers]

Estrogen receptor α and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women

Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle

Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis

Seasonal and Treatment-Related Variation in 25-Hydroxy Vitamin D Concentration in Patients with Rheumatoid Arthritis

L-shaped Association Between Serum 25-Hydroxyvitamin D and All-Cause Mortality of Individuals with Rheumatoid Arthritis

Analysis of Potential Vitamin D Molecule Biomarkers: Association of Calcitriol and Its Hydroxylation Efficiency Ratio with Cardiovascular Disease Risk in Rheumatoid Arthritis Patients

Relationship between serum vitamin D levels and the prevalence of knee osteoarthritis: A retrospective study on 3424 subjects

Anterograde transneuronal viral tract tracing reveals central sensory circuits from brown fat and sensory denervation alters its thermogenic responses.

Associations between the VDR Gene rs731236 (TaqI) Polymorphism and Bone Mineral Density in Postmenopausal Women from the RAC-OST-POL

The association of osteopenia with levels of serum 25-hydroxyvitamin D and HOMA-IR values

A Mendelian Randomization Study on the Role of Serum Parathyroid Hormone and 25-Hydroxyvitamin D in Osteoarthritis.

Association Between Serum Levels Of 25-Hydroxyvitamin D And Osteoarthritis: A Systematic Review

Vitamin D and vitamin K status in postmenopausal women with normal and low bone mineral density

Relationship between Serum 25-hydroxyvitamin D and Bone Mineral Density, Fracture Risk, and Bone Metabolism in Adults with Osteoporosis/Fractures